Citigroup
ZURA icon

Citigroup’s Zura Bio ZURA Stock Holding History

Citigroup’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$164K Buy
27,763
+18,354
+195% +$87.4K ﹤0.01% 4437
2026
Q1 		$56K Sell
9,409
-30,350
-76% -$183K ﹤0.01% 4484
2025
Q4 		$208K Buy
39,759
+39,702
+69,653% +$157K ﹤0.01% 3988
2025
Q3 		$247 Sell
57
-9,122
-99% -$16.4K ﹤0.01% 5751
2025
Q2 		$9.64K Sell
9,179
-26,789
-74% -$32K ﹤0.01% 5196
2025
Q1 		$46.4K Sell
35,968
-3,598
-9% -$5.67K ﹤0.01% 4885
2024
Q4 		$98.9K Buy
39,566
+7,468
+23% +$26.6K ﹤0.01% 4846
2024
Q3 		$130K Buy
32,098
+27,741
+637% +$104K ﹤0.01% 4632
2024
Q2 		$15.3K Buy
4,357
+1,162
+36% +$4.74K ﹤0.01% 5063
2024
Q1 		$8.21K Buy
3,195
+683
+27% +$2.42K ﹤0.01% 5244
2023
Q4 		$11.7K Buy
2,512
+2,506
+41,767% +$12.5K ﹤0.01% 5152
2023
Q3 		$39 Sell
6
-2,252
-100% -$15.1K ﹤0.01% 5545
2023
Q2 		$18.5K Buy
+2,258
New +$18.1K ﹤0.01% 4977

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Citigroup's ZURA Position: Q2 2026 in Review

Citigroup increased its Zura Bio (ZURA) stake by 195% in Q2 2026, buying an estimated $87.4K and bringing the position to 27,763 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #4437.

Citigroup first reported a position in ZURA in Q2 2023 and has held it in 13 quarters since. The position peaked at $208K in Q4 2025. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Citigroup held 27,763 shares of Zura Bio worth $164K as of Q2 2026.
  • Citigroup bought 18,354 Zura Bio shares in Q2 2026, an estimated $87.4K.
  • Zura Bio made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4437 holding.
  • Citigroup first reported a position in Zura Bio in Q2 2023 and has held it in 13 quarters since.
  • Citigroup's Zura Bio position peaked at $208K in Q4 2025.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.